These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3709643)

  • 21. [Pharmacodynamic effects of the sustained-release tablet of isosorbide dinitrate and its bioavailability in conscious dogs (author's transl)].
    Kogi K; Chida S; Kimura T; Saito T
    Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):99-107. PubMed ID: 7399370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bioavailability and bioequivalence of organic nitrates. Isosorbide dinitrate--a study of sustained-release preparations].
    Scheidel B; Blume H; Stenzhorn G; Siewert M; Babej-Dölle RM
    Arzneimittelforschung; 1991 Mar; 41(3):212-8. PubMed ID: 1867657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man.
    Shane SJ; Iazzetta JJ; Chisholm AW; Berka JF; Leung D
    Br J Clin Pharmacol; 1978 Jul; 6(1):37-41. PubMed ID: 666946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of beta-blocker coadministration on the kinetics of isosorbide mononitrate and dinitrate.
    Ochs HR; Neugebauer G; Greenblatt DJ; Labedzki L
    Klin Wochenschr; 1986 Dec; 64(23):1213-6. PubMed ID: 2879959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of isosorbide-5-mononitrate, a major metabolite of isosorbide dinitrate (ISDN), to the hemodynamic effect of ISDN administered orally in conscious dogs.
    Kogi K; Satoh T
    Jpn J Pharmacol; 1987 Jul; 44(3):249-57. PubMed ID: 3656782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentrations of isosorbide dinitrate after administration of increasing doses of a sustained-release formulation to human subjects.
    Taylor T; O'Kelly DA; Major RM; Darragh A; Chasseaud LF
    Arzneimittelforschung; 1978; 28(8):1426-8. PubMed ID: 582411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.
    Wallén NH; Larsson PT; Bröijersén A; Andersson A; Hjemdahl P
    Br J Clin Pharmacol; 1993 Feb; 35(2):143-51. PubMed ID: 8443032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina.
    Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Bechtold H; Meinertz T; Fung HL
    Clin Pharmacol Ther; 1983 Jun; 33(6):747-56. PubMed ID: 6851405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations and bioavailability of isosorbide dinitrate and pindolol from a combination formulation.
    Chasseaud LF; Doyle E; Taylor T; Darragh A
    Biopharm Drug Dispos; 1981; 2(3):273-81. PubMed ID: 7295884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance to isosorbide dinitrate: rate of development and reversal.
    Parker JO; Fung HL; Ruggirello D; Stone JA
    Circulation; 1983 Nov; 68(5):1074-80. PubMed ID: 6616789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
    Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentrations and coronary vasodilation after sublingual and intracoronary administration of isosorbide dinitrate.
    Hoshio A; Shirota K; Sasaki N; Doi T; Sawada Y; Fukuki M; Miyakoda H; Kotake H; Mashiba H
    Clin Cardiol; 1995 Nov; 18(11):641-6. PubMed ID: 8590533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions].
    Rietbrock N; Knoll J; Merz PG; Menke G
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1821-5. PubMed ID: 3905327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of isosorbide dinitrate saliva concentrations for biopharmaceutical investigations.
    Laufen H; Schmid M; Leitold M
    J Pharm Sci; 1983 May; 72(5):496-9. PubMed ID: 6864494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
    Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
    Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple and sensitive gas chromatography method for determination of isosorbide dinitrate and its metabolites in human plasma: application to pharmacokinetics study on oral spray.
    Jiang Z; Wei C; Sun Z; Guo J; Li R; Zhang R; Yuan G; Guo R
    Drug Res (Stuttg); 2014 Feb; 64(2):73-8. PubMed ID: 23904215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamics and plasma concentrations following sublingual GTN and intravenous, or inhaled, isosorbide dinitrate.
    Culling W; Singh H; Bashir A; Griffiths BE; Dalal JJ; Sheridan DJ
    Br J Clin Pharmacol; 1984 Feb; 17(2):125-31. PubMed ID: 6422972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assay of plasma isosorbide dinitrate and its metabolites after oral administration of immediate and delayed-action forms].
    Audry E; Dallet P; Dubost JP; Langlois MH; Ernouf D; Narcisse G
    Ann Pharm Fr; 1989; 47(4):235-41. PubMed ID: 2637644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs].
    Kogi K; Tanaka O; Kimura T; Saito T
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.